GLP-1: Broadening the incretin concept to involve gut motility
- 1 August 2009
- journal article
- review article
- Published by Elsevier in Regulatory Peptides
- Vol. 156 (1-3) , 9-12
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- Effects of glucagon‐like peptide‐1 and sympathetic stimulation on gastric accommodation in humans1Neurogastroenterology & Motility, 2007
- Erythromycin Antagonizes the Deceleration of Gastric Emptying by Glucagon-Like Peptide 1 and Unmasks Its Insulinotropic Effect in Healthy SubjectsDiabetes, 2005
- Normalization of Glucose Concentrations and Deceleration of Gastric Emptying after Solid Meals during Intravenous Glucagon-Like Peptide 1 in Patients with Type 2 DiabetesThe Journal of Clinical Endocrinology & Metabolism, 2003
- Effects of glucagon-like peptide-1(7–36)amide on motility and sensation of the proximal stomach in humansGut, 2002
- Antidiabetogenic action of glucagon-like peptide-1 related to administration relative to meal intake in subjects with type 2 diabetesJournal of Internal Medicine, 2001
- GLP-1 Inhibits Gastric Emptying of Water but Does Not Influence Plasma Vasopressin, Sodium, or OsmolalityScandinavian Journal of Gastroenterology, 2001
- Energy intake and appetite are suppressed by glucagon-like peptide-1 (GLP-1) in obese men.International Journal of Obesity, 1999
- Glucagon-like peptide 1 increases the period of postprandial satiety and slows gastric emptying in obese menThe American Journal of Clinical Nutrition, 1998
- Relation between gastric emptying of glucose and plasma concentrations of glucagon-like peptide-1Peptides, 1998
- Glucagon-Like Peptide I Enhances the Insulinotropic Effect of Glibenclamide in NIDDM Patients and in the Perfused Rat PancreasDiabetes Care, 1996